StreetAlpha.app
Home › Stocks › TNDM

Tandem Diabetes Care Inc (TNDM)

Healthcare
$17.06
▼ −7.68%
LAST CLOSE · NOV 17

Tandem Diabetes Care makes insulin pumps and related diabetes technology for people with insulin-dependent diabetes. It last closed at $17.06 on Nov 17, down 7.68% on the day. The average 12-month price target from 4 analysts is $23.25 (+36.3% from the last close), with a high of $28.00 and a low of $20.00. Analyst consensus is Buy, based on the latest ratings from 4 firms (2 buy, 2 hold, 0 sell). In the past 30 days there were 1 dark pool print totaling $3.8M, the largest $3.8M.

AI Auto Pilots
Is TNDM in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$1.1B
+6.8% vs a year ago
Net income
−$49.2M
−4.6% margin
EPS (diluted)
−$0.70
Free cash flow
−$36.3M
−3.4% margin
Valuation
Market cap
$1.2B
69.8M shares
P/E
–
No P/E while losing money
Price to sales
1.1
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$72.8M
At Sep 30
Debt
$603.4M
At Sep 30
Shareholder equity
$135.1M
Shares outstanding
69.8M
At Nov 2
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $702.8M$702.8MFY2021FY2022: $801.2M$801.2MFY2022FY2023: $747.7M$747.7MFY2023FY2024: $940.2M$940.2MFY2024FY2025: $1.0B$1.0BFY2025

From TNDM's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Last report
Nov 5
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
Buy
Based on 4 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
4firms
2 Buy2 Hold0 Sell
Each firm's latest rating on TNDM in the past 90 days
Average 12-month target
$23.25
▲ 36.3% upside

Based on 4 analysts who set a price target on TNDM in the past 90 days. The average target is $23.25, with a high of $28.00 and a low of $20.00, compared with the last close of $17.06.

Low $20.00Avg $23.25High $28.00
Blue marker: last close $17.06
Highest target$28.00
Average target$23.25
Lowest target$20.00
Latest rating changes
BarclaysTarget raised
Nov 6Hold$18 → $20
Wells FargoTarget lowered
Nov 6Buy$27 → $25
BarclaysInitiated
Oct 7Hold$18
CitigroupTarget lowered
Sep 30Hold$21 → $20
Truist SecuritiesTarget lowered
Sep 24Buy$35 → $28
DateFirmActionRatingPrice target
Nov 6BarclaysTarget raisedHold$18 → $20
Nov 6Wells FargoTarget loweredBuy$27 → $25
Oct 7BarclaysInitiatedHold$18
Sep 30CitigroupTarget loweredHold$21 → $20
Sep 24Truist SecuritiesTarget loweredBuy$35 → $28
Loading…

Technical Analysis

TNDM · as of the Nov 17 close · updated after every close
Moving sideways

The stock is 7% below its 20 day and 1% below its 50 day average. It is 10% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 46). The nearest support is the Pivot S1 at $16.52, and the nearest resistance the swing high (Jun 16) at $17.20.

Short trendNeutral
Long trendBearish
MomentumFading
StretchNormal
VolatilityHigh, 8.2%/day
Key levels
$29.6552 week high+73.8%
$18.82200 day average+10.3%
$18.3320 day average+7.4%
$18.27100 day average+7.1%
$18.12Pivot R1+6.2%
$17.58Pivot+3.0%
$17.3150 day average+1.5%
$17.20Swing high (Jun 16)+0.8%
$17.06Last close
$16.52Pivot S1−3.2%
$16.14Swing low (Jul 23)−5.4%
$12.2652 week low−28.1%
Indicators
RSI (14)45.90Middle of its rangeNeutral
MACD0.21Below its signal lineBearish
Stochastic64.2Middle of its rangeNeutral
ADX (14)15.1No clear trend
Williams %R-66.5Oversold below −80, overbought above −20Neutral
CCI (20)-60.7Oversold below −100, overbought above 100Neutral
Rate of change−3.3%Change over 10 sessionsBearish
ATR (14)$1.41Typical daily range, 8.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TNDM

What happened before

See how TNDM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow TNDM usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How TNDM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2013.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in TNDM in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$3.8M
Largest print
$3.8M
Loading…

TNDM Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●127 buying vs 139 selling
  • ▲Held by funds +3.3 pts
  • ▼Funds holding -11
  • ▲Superinvestors: 3 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding269280−3.9%
In funds' top 1021+100.0%
Held by funds117.0%113.7%+3.3 pts
New / increased38 / 8948 / 96−11.8%
Reduced / sold out90 / 4992 / 44+2.2%
Put/call ratio15.880.22+7044.4%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TNDM institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TNDM is in one of them and how their past TNDM trades turned out.

TNDM in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TNDM in an article yet. Here's the latest on the wider market.

TNDM Congress Trades

All congress trades →
Trades, 12 months
7
Buys
4
57%
Sells
2
29%
People
2
Last filed Oct 12
Who traded TNDM · since 2022
Latest 5 filings of 15
$1K – $15KTraded Sep 29, 2026Filed Oct 12, 2026
$15K – $50KTraded Jul 29, 2026Filed Sep 22, 2026
$15K – $50KTraded Jul 17, 2026Filed Sep 22, 2026
$1K – $15KTraded May 15, 2026Filed Jul 1, 2026
$15K – $50KTraded Mar 30, 2026Filed May 14, 2026
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KSep 29, 2026Oct 12, 202613 d
Donald J TrumpExecutive branchSell$15K – $50KJul 29, 2026Sep 22, 202655 d
Donald J TrumpExecutive branchBuy$15K – $50KJul 17, 2026Sep 22, 202667 d
Donald J TrumpExecutive branchSell$1K – $15KMay 15, 2026Jul 1, 202647 d
Donald J TrumpExecutive branchOther$15K – $50KMar 30, 2026May 14, 202645 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Tandem Diabetes Care

Tandem Diabetes Care is a San Diego, California company that designs, develops and sells insulin delivery systems for people with diabetes. Its main products are insulin pumps, including the t:slim X2 and Mobi, along with single use supplies that connect to them. The company also offers software tools, such as Tandem Source, a data platform for users, caregivers and healthcare providers, and the Sugarmate app. Its customers are mainly people with type 1 diabetes and, in the United States, people with type 2 diabetes who need intensive insulin therapy.

Headquarters
San Diego, CA
Founded
2008